Get started
Author

Paolo Cameli

Observed names: Cameli P, Cameli Paolo, Cameli, P., Cameli, Paolo, P Cameli, P. Cameli, Paolo CAMELI, Paolo Cameli (8467695), paolo cameli
Observed institutions: University of Siena, Wellcome Sanger Institute, Ospedale Santa Maria alle Scotte, Azienda Ospedaliera Universitaria Senese, Stanford Medicine, Ospedale Misericordia - Grosseto, Imperial College London, Stanford University
ORCID: 0000-0001-8639-2882
Observed ORCID: 0000-0001-8639-2882
OpenAlex ID: A5013985509
Mapping the human genetic architecture of COVID-19
2021 · COVID-19 Host Genetics Initiative, COVID-19 Host Genetics InitiativeLeadership, et al. · Nature · 983
Whole-genome sequencing reveals host factors underlying critical COVID-19
2022 · Athanasios Kousathanas, Erola Pairo-Castineira, et al. · Nature · 326
PDF
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population
2020 · Elisa Benetti, Rossella Tita, et al. · European Journal of Human Genetics · 263
PDF
Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study
2021 · Chiara Fallerini, Sergio Daga, et al. · eLife · 198
A first update on mapping the human genetic architecture of COVID-19
2022 · COVID-19 Host Genetics Initiative, COVID-19 Host Genetics Initiative, et al. · Nature · 181
PDF
Comparison of Right Versus Left Ventricular Strain Analysis as a Predictor of Outcome in Patients With Systolic Heart Failure Referred for Heart Transplantation
2013 · Matteo Cameli, Francesca Maria Righini, et al. · The American Journal of Cardiology · 100
Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19
2020 · Miriana d'Alessandro, Paolo Cameli, et al. · Journal of Medical Virology · 98
PDF
Effects of rituximab therapy on B cell differentiation and depletion
2020 · L. Bergantini, M. d’Alessandro, et al. · Clinical Rheumatology · 94
Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis
2019 · Paolo Cameli, Alfonso Carleo, et al. · Inflammation · 94
Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study
2020 · Paolo Cameli, Rosa Metella Refini, et al. · Frontiers in Molecular Biosciences · 89
PDF
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis
2020 · David Bennett, Paolo Cameli, et al. · Respiratory Research · 86
PDF
Krebs Von Den Lungen-6 As A Biomarker for Disease Severity Assessment in Interstitial Lung Disease: A Comprehensive Review
2020 · Miriana d’Alessandro, Laura Bergantini, et al. · Biomarkers in Medicine · 81
Left atrial strain as a pre-operative prognostic marker for patients with severe mitral regurgitation
2020 · Giulia Elena Mandoli, Maria Concetta Pastore, et al. · International Journal of Cardiology · 80
Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6
2019 · Laura Bergantini, Francesco Bianchi, et al. · Disease Markers · 74
PDF
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients
2021 · Stefania Mantovani, Sergio Daga, et al. · Genes and Immunity · 69
PDF
Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis
2020 · Elena Bargagli, Rosa Metella Refini, et al. · International Journal of Molecular Sciences · 67
PDF
Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life
2020 · Bruno Sposato, Gianna Camiciottoli, et al. · Pulmonary Pharmacology & Therapeutics · 66
PDF
BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases
2020 · Miriana d’Alessandro, Alfonso Carleo, et al. · Clinical and Experimental Medicine · 63
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males
2021 · Margherita Baldassarri, Nicola Picchiotti, et al. · EBioMedicine · 62
PDF
Basic and advanced echocardiography in advanced heart failure: an overview
2019 · Maria Concetta Pastore, Giulia Elena Mandoli, et al. · Heart Failure Reviews · 60
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting
2020 · Miriana d'Alessandro, Felice Perillo, et al. · International Immunopharmacology · 57
Usefulness of echocardiography to detect cardiac involvement in COVID‐19 patients
2020 · Matteo Cameli, Maria Concetta Pastore, et al. · Echocardiography · 53
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs
2020 · Edoardo Conticini, Elena Bargagli, et al. · Annals of the Rheumatic Diseases · 52
Serum amyloid A: A potential biomarker of lung disorders
2019 · Lucia Vietri, Annalisa Fui, et al. · Respiratory Investigation · 50
NK and NKT-like cells in granulomatous and fibrotic lung diseases
2019 · L Bergantini, P Cameli, et al. · Clinical and Experimental Medicine · 50
Works count: 335
Citation count: 6,324
H-index: 39
I10-index: 128
Year
Topic
Type